Vitolo Marco, Proietti Marco, Imberti Jacopo F, Bonini Niccolò, Romiti Giulio Francesco, Mei Davide A, Malavasi Vincenzo L, Diemberger Igor, Fauchier Laurent, Marin Francisco, Nabauer Michael, Potpara Tatjana S, Dan Gheorghe-Andrei, Lip Gregory Y H, Boriani Giuseppe
Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, 41124 Modena, Italy.
Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University, Liverpool Heart & Chest Hospital, Liverpool L14 3PE, UK.
J Clin Med. 2023 Jan 18;12(3):768. doi: 10.3390/jcm12030768.
Paroxysmal atrial fibrillation (AF) may often progress towards more sustained forms of the arrhythmia, but further research is needed on the factors associated with this clinical course.
We analyzed patients enrolled in a prospective cohort study of AF patients. Patients with paroxysmal AF at baseline or first-detected AF (with successful cardioversion) were included. According to rhythm status at 1 year, patients were stratified into: (i) No AF progression and (ii) AF progression. All-cause death was the primary outcome.
A total of 2688 patients were included (median age 67 years, interquartile range 60-75, females 44.7%). At 1-year of follow-up, 2094 (77.9%) patients showed no AF progression, while 594 (22.1%) developed persistent or permanent AF. On multivariable logistic regression analysis, no physical activity (odds ratio [OR] 1.35, 95% CI 1.02-1.78), valvular heart disease (OR 1.63, 95% CI 1.23-2.15), left atrial diameter (OR 1.03, 95% CI 1.01-1.05), or left ventricular ejection fraction (OR 0.98, 95% CI 0.97-1.00) were independently associated with AF progression at 1 year. After the assessment at 1 year, the patients were followed for an extended follow-up of 371 days, and those with AF progression were independently associated with a higher risk for all-cause death (adjusted hazard ratio 1.77, 95% CI 1.09-2.89) compared to no-AF-progression patients.
In a contemporary cohort of AF patients, a substantial proportion of patients presenting with paroxysmal or first-detected AF showed progression of the AF pattern within 1 year, and clinical factors related to cardiac remodeling were associated with progression. AF progression was associated with an increased risk of all-cause mortality.
阵发性心房颤动(AF)常可进展为更持续的心律失常形式,但关于与此临床病程相关的因素仍需进一步研究。
我们分析了纳入房颤患者前瞻性队列研究的患者。纳入基线时为阵发性房颤或首次检测到房颤(且成功复律)的患者。根据1年时的心律状态,将患者分为:(i)无房颤进展组和(ii)房颤进展组。全因死亡是主要结局。
共纳入2688例患者(中位年龄67岁,四分位间距60 - 75岁,女性占44.7%)。在1年随访时,2094例(77.9%)患者无房颤进展,而594例(22.1%)发展为持续性或永久性房颤。多变量逻辑回归分析显示,无体力活动(比值比[OR] 1.35,95%可信区间1.02 - 1.78)、瓣膜性心脏病(OR 1.63,95%可信区间1.23 - 2.15)、左心房直径(OR 1.03,95%可信区间1.01 - 1.05)或左心室射血分数(OR 0.98,95%可信区间0.97 - 1.00)与1年时的房颤进展独立相关。在1年评估后,对患者进行了371天的延长随访,与无房颤进展的患者相比,房颤进展的患者全因死亡风险更高(校正风险比1.77,95%可信区间1.09 - 2.89)。
在当代房颤患者队列中,相当一部分阵发性或首次检测到房颤的患者在1年内出现房颤模式进展,与心脏重塑相关的临床因素与进展有关。房颤进展与全因死亡率增加相关。